Observational Retrospective Study in Patients Treated with Galcanezumab as Preventive Treatment for Migraine: The ORYGAM Study

Abstract Introduction The efficacy of galcanezumab has been demonstrated in randomized controlled trials, but evidence about its use under clinical practice conditions is still limited. This study aimed to describe the characteristics of the patients treated with galcanezumab in routine clinical pra...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Samuel Díaz Insa, Ángel Guerrero, Javier Viguera, Vicente Medrano Martínez, Carlos Calle de Miguel, Jesús Porta-Etessam, Antonio Ciudad, Silvia Diaz-Cerezo, Ana Roncero Martín, Mercedes Núñez
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2024-03-01
Colecção:	Pain and Therapy
Assuntos:	Antibody Calcitonin gene-related peptide Galcanezumab Migraine Persistence Real-life
Acesso em linha:	https://doi.org/10.1007/s40122-024-00586-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!